A G Fedorov
Research Subjects
A G Fedorov has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- S V Davydova
Peoples’ Friendship University
4 shared publications A E Klimov
2 shared publications- Aleksey E. Klimov
Peoples’ Friendship University of Russia named after Patrice Lumumba
2 shared publications - O.A. Yun
Buyanov Moscow City Clinical Hospital
2 shared publications A S Gaboyan
1 shared publicationN V Lebedev
1 shared publication
Latest Publications
- 7 June 2024
- Published by Media Sphere Publishing Group in Endoscopic Surgery
- Vol. 30 (3)
Palliative large-bowel decompression for colorectal obstruction in patients with unresectable locally advanced cancer and carcinomatosis
OBJECTIVE Evaluation clinical outcomes of stenting and decompressive surgery in patients with colorectal obstruction due to unresectable locally advanced cancer and carcinomatosis. MATERIAL AND METHODS A retrospective analysis of palliative treatment of 73 patients with large-bowel obstruction was performed. Criterion of inclusion — presence of unresectable primary, recurrent or metastatic locally advanced tumour with invasion to adjacent tissues and/or peritoneal dissemination. Patients underwent colorectal stenting (39) or decompressive surgery (34) (loop colostomy — 29, ileotransverse bypass — 5). Left-sided obstruction was observed in 64 (35/29) patients, right-sided — in 9 (4/5) patients. Location of tumour: colorectal cancer — 57 (29/28), extracolonic tumour — 16 (10/6) patients. RESULTS Complications occurred in 3 patients (7.7%) after stenting and in 11 (32.4%) after surgical palliation (p=0.0083) with post-procedure mortality 5.1% (2 patients) vs. 14.7% (5 patients), p=0.2675. Stoma complications and wound infection prevailed among surgical adverse events; all stent-related complications included bowel perforation. General adverse events were observed in 5 patients after colostomy vs. 0 after stenting (p=0.0185). Hospital stay was shorter for stenting (p=0.0010). CONCLUSION Stenting and loop colostomy or bypass appear to be equally effective for management of large bowel obstruction in patients with locally advanced unresectable cancer of various etiology, including extracolonic, recurrent and metastatic tumours. In comparison to decompressive surgery colorectal stenting is less invasive, has an advantage of fewer adverse events, shorter hospital stay, absence of stoma and therefore may be recommended as a final palliation.
- 7 June 2024
- Published by Media Sphere Publishing Group in Endoscopic Surgery
- Vol. 30 (3)
Palliative large-bowel decompression for colorectal obstruction in patients with unresectable locally advanced cancer and carcinomatosis
OBJECTIVE Evaluation clinical outcomes of stenting and decompressive surgery in patients with colorectal obstruction due to unresectable locally advanced cancer and carcinomatosis. MATERIAL AND METHODS A retrospective analysis of palliative treatment of 73 patients with large-bowel obstruction was performed. Criterion of inclusion — presence of unresectable primary, recurrent or metastatic locally advanced tumour with invasion to adjacent tissues and/or peritoneal dissemination. Patients underwent colorectal stenting (39) or decompressive surgery (34) (loop colostomy — 29, ileotransverse bypass — 5). Left-sided obstruction was observed in 64 (35/29) patients, right-sided — in 9 (4/5) patients. Location of tumour: colorectal cancer — 57 (29/28), extracolonic tumour — 16 (10/6) patients. RESULTS Complications occurred in 3 patients (7.7%) after stenting and in 11 (32.4%) after surgical palliation (p=0.0083) with post-procedure mortality 5.1% (2 patients) vs. 14.7% (5 patients), p=0.2675. Stoma complications and wound infection prevailed among surgical adverse events; all stent-related complications included bowel perforation. General adverse events were observed in 5 patients after colostomy vs. 0 after stenting (p=0.0185). Hospital stay was shorter for stenting (p=0.0010). CONCLUSION Stenting and loop colostomy or bypass appear to be equally effective for management of large bowel obstruction in patients with locally advanced unresectable cancer of various etiology, including extracolonic, recurrent and metastatic tumours. In comparison to decompressive surgery colorectal stenting is less invasive, has an advantage of fewer adverse events, shorter hospital stay, absence of stoma and therefore may be recommended as a final palliation.
- 23 April 2023
- Published by Media Sphere Publishing Group in Endoscopic Surgery
- Vol. 29 (6)
Clinical outcomes of colorectal stenting
Objective. The aim of retrospective study was to evaluate early and long-term outcomes of colorectal stenting. Material and methods. 101 patients presenting with symptomatic colorectal obstruction at the period of 2010—2020 underwent an attempt of stenting. Stenosis due to colorectal cancer (92) or extracolonic malignancies (9) was located in left half of large bowel in 85 patients (rectum and rectosigmoid — 43, left colon — 42), in right colon — in 16 patients. Effectiveness of stent placement, adverse events and survival were analyzed. Results. Technical and functional success of stenting was achieved in 99 patients (98%). Attempt of stent placement failed in 2 cases of ascending colon cancer, technical success in right colon — 88%. Early complications were observed in 8 patients (7.9%): colonic perforation with peritonitis (3), extraperitoneal rectal perforation (1), pelvic abscess in combination with stent dislocation (1), and distal migration of covered stents (3). 3 perforations at the tumor site occurred on the first-second days, one was delayed and revealed on the 11th day after procedure. Two cases of peritonitis resulted in death, stent-associated mortality — 2%. 3 patients underwent radical resections. Recurrence of obstructive symptoms due to stent occlusion in 8—20 months after palliative stenting occurred in 4 patients. Conclusion. Stenting is a valid technique to treat malignant colorectal obstruction. The main complication in cases of locally advanced cancer is bowel perforation. Placement of covered stents is associated with an increased risk of migration.
- 23 April 2023
- Published by Media Sphere Publishing Group in Endoscopic Surgery
- Vol. 29 (6)
Clinical outcomes of colorectal stenting
Objective. The aim of retrospective study was to evaluate early and long-term outcomes of colorectal stenting. Material and methods. 101 patients presenting with symptomatic colorectal obstruction at the period of 2010—2020 underwent an attempt of stenting. Stenosis due to colorectal cancer (92) or extracolonic malignancies (9) was located in left half of large bowel in 85 patients (rectum and rectosigmoid — 43, left colon — 42), in right colon — in 16 patients. Effectiveness of stent placement, adverse events and survival were analyzed. Results. Technical and functional success of stenting was achieved in 99 patients (98%). Attempt of stent placement failed in 2 cases of ascending colon cancer, technical success in right colon — 88%. Early complications were observed in 8 patients (7.9%): colonic perforation with peritonitis (3), extraperitoneal rectal perforation (1), pelvic abscess in combination with stent dislocation (1), and distal migration of covered stents (3). 3 perforations at the tumor site occurred on the first-second days, one was delayed and revealed on the 11th day after procedure. Two cases of peritonitis resulted in death, stent-associated mortality — 2%. 3 patients underwent radical resections. Recurrence of obstructive symptoms due to stent occlusion in 8—20 months after palliative stenting occurred in 4 patients. Conclusion. Stenting is a valid technique to treat malignant colorectal obstruction. The main complication in cases of locally advanced cancer is bowel perforation. Placement of covered stents is associated with an increased risk of migration.
- 1 January 2015
- No. 4,p. 71-6
[STENTING VERSUS PALLIATIVE SURGERY IN PATIENTS WITH MALIGNANT GASTROINTESTINAL STENOSIS].
Retrospective analysis of the results of stenting versus surgical palliation in patients with malignant gastrointestinal stenosis. 85 patients underwent endoscopic stenting (41) or surgical intervention (44). Level of stenosis: gastric outlet (23/38), multi-level gastric obstruction (2/3), duodenum or jejunum (12/3), gastrojejunoanastomosis (3/0) and gastroduodenoanastomosis (1/0). 49 self-expanding metal stents were implanted in 41 patients. 41 gastroenteroanastomoses and 3 jejunostomas were performed in surgical group. Stents were successfully inserted in all patients. Early complications were observed in 3 (7.3%) patients after stenting and in 9 (20.5%) after surgical palliation, p = 0.0755. Postoperative lethality was 2,4% (1 patient) after stenting and 31.8% (14 patients) after surgery, p = 0.0003. Mean hospital stay was 15 days in stenting group and 23 days in surgical group, p < 0.001. There was no statistically significant difference in long-term results, neither in late complications (p = 0.3691), nor in survival (p =0.3697). Endoscopic placement of self-expanding stents is an effective method of restoration of oral intake in patients with malignant gastrointestinal obstruction. Stenting is associated with equal rates of early and late complications, lower mortality and decreased in-hospital stay as compared with surgery, and therefore may be recommended as a final palliation in inoperable patients.
- 1 January 2015
- No. 4,p. 71-6
[STENTING VERSUS PALLIATIVE SURGERY IN PATIENTS WITH MALIGNANT GASTROINTESTINAL STENOSIS].
Retrospective analysis of the results of stenting versus surgical palliation in patients with malignant gastrointestinal stenosis. 85 patients underwent endoscopic stenting (41) or surgical intervention (44). Level of stenosis: gastric outlet (23/38), multi-level gastric obstruction (2/3), duodenum or jejunum (12/3), gastrojejunoanastomosis (3/0) and gastroduodenoanastomosis (1/0). 49 self-expanding metal stents were implanted in 41 patients. 41 gastroenteroanastomoses and 3 jejunostomas were performed in surgical group. Stents were successfully inserted in all patients. Early complications were observed in 3 (7.3%) patients after stenting and in 9 (20.5%) after surgical palliation, p = 0.0755. Postoperative lethality was 2,4% (1 patient) after stenting and 31.8% (14 patients) after surgery, p = 0.0003. Mean hospital stay was 15 days in stenting group and 23 days in surgical group, p < 0.001. There was no statistically significant difference in long-term results, neither in late complications (p = 0.3691), nor in survival (p =0.3697). Endoscopic placement of self-expanding stents is an effective method of restoration of oral intake in patients with malignant gastrointestinal obstruction. Stenting is associated with equal rates of early and late complications, lower mortality and decreased in-hospital stay as compared with surgery, and therefore may be recommended as a final palliation in inoperable patients.
- 1 January 2013
- No. 9,p. 34-8
[Results of the upper digestive tract stenting with self-expanding stents].
The work is based on the analysis of the palliative treatment of 66 patients with malignant upper digestive tract obstruction who underwent implantation of 75 self-expanding metallic stents in the period of 2003-2012 yy. Early postoperative complications developed in 10 (15.2%) cases. Procedure-related complications were observed in 8 (12.1%) patients, non-specific complications occurred in 2 (3.0%) patients. In-hospital lethality was 4.5% (3 patients). 51 patients were followed until death. Symptomatic relapse of obstruction was observed in 4 cases. Median survival was 97 days. Stenting with self-expanding metal stents was concluded to be an effective and safe method of palliation of malignant upper digestive tract stenosis.
- 1 January 2013
- No. 9,p. 34-8
[Results of the upper digestive tract stenting with self-expanding stents].
The work is based on the analysis of the palliative treatment of 66 patients with malignant upper digestive tract obstruction who underwent implantation of 75 self-expanding metallic stents in the period of 2003-2012 yy. Early postoperative complications developed in 10 (15.2%) cases. Procedure-related complications were observed in 8 (12.1%) patients, non-specific complications occurred in 2 (3.0%) patients. In-hospital lethality was 4.5% (3 patients). 51 patients were followed until death. Symptomatic relapse of obstruction was observed in 4 cases. Median survival was 97 days. Stenting with self-expanding metal stents was concluded to be an effective and safe method of palliation of malignant upper digestive tract stenosis.